Correlation Between Elicio Therapeutics and Novartis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Elicio Therapeutics and Novartis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elicio Therapeutics and Novartis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elicio Therapeutics and Novartis AG ADR, you can compare the effects of market volatilities on Elicio Therapeutics and Novartis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elicio Therapeutics with a short position of Novartis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elicio Therapeutics and Novartis.

Diversification Opportunities for Elicio Therapeutics and Novartis

-0.59
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Elicio and Novartis is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Elicio Therapeutics and Novartis AG ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novartis AG ADR and Elicio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elicio Therapeutics are associated (or correlated) with Novartis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novartis AG ADR has no effect on the direction of Elicio Therapeutics i.e., Elicio Therapeutics and Novartis go up and down completely randomly.

Pair Corralation between Elicio Therapeutics and Novartis

Given the investment horizon of 90 days Elicio Therapeutics is expected to generate 3.71 times more return on investment than Novartis. However, Elicio Therapeutics is 3.71 times more volatile than Novartis AG ADR. It trades about 0.0 of its potential returns per unit of risk. Novartis AG ADR is currently generating about -0.24 per unit of risk. If you would invest  506.00  in Elicio Therapeutics on August 26, 2024 and sell it today you would lose (13.00) from holding Elicio Therapeutics or give up 2.57% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Elicio Therapeutics  vs.  Novartis AG ADR

 Performance 
       Timeline  
Elicio Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Elicio Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Elicio Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Novartis AG ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Novartis AG ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Elicio Therapeutics and Novartis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Elicio Therapeutics and Novartis

The main advantage of trading using opposite Elicio Therapeutics and Novartis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elicio Therapeutics position performs unexpectedly, Novartis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novartis will offset losses from the drop in Novartis' long position.
The idea behind Elicio Therapeutics and Novartis AG ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments